Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737953-25-000013
Filing Date
2025-08-07
Accepted
2025-08-07 08:07:39
Documents
88
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q repl-20250630.htm   iXBRL 10-Q 1320379
2 EX-10.1 amendment_consultingagreem.htm EX-10.1 11565
3 EX-31.1 repl-6302025x10qxex311.htm EX-31.1 10838
4 EX-31.2 repl-6302025x10qxex312.htm EX-31.2 10568
5 EX-32.1 repl-6302025x10qxex321.htm EX-32.1 5097
6 EX-32.2 repl-6302025x10qxex322.htm EX-32.2 5108
  Complete submission text file 0001737953-25-000013.txt   7130163

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repl-20250630.xsd EX-101.SCH 59110
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repl-20250630_cal.xml EX-101.CAL 86428
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repl-20250630_def.xml EX-101.DEF 221856
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT repl-20250630_lab.xml EX-101.LAB 702202
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repl-20250630_pre.xml EX-101.PRE 484074
91 EXTRACTED XBRL INSTANCE DOCUMENT repl-20250630_htm.xml XML 836594
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 251191748
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)